Tag: CBT > Cannabis DEA: Page 4

Cannabis Rescheduling

US Congressmen Press DEA Head to Explain Her Signature Absence on Cannabis Rescheduling Document

The agency’s administrator, Anne Milgram, did not personally approve the notice of proposed rulemaking to reclassify cannabis on May 16.

May 23, 2024

Banking Services Cannabis Industry

Federal Marijuana Rescheduling on the Horizon: A Big Step Forward But Not the Be-All-End-All

Rescheduling does not make cannabis legal throughout America and the U.S. territories; It makes cannabis a federally regulated medication—and many questions remain about the fate of the industry.

May 23, 2024

Cannabis Rescheduling

Cannabis Industry Reacts to Biden’s Rescheduling Announcement

The President’s May 16 announcement is being touted as an important and historic first step, but many industry constituents say there’s still a long way to go, with social justice at the heart of pushes for decriminalization. Here are reactions from cannabis business executives, industry organizations, lawyers and members of Congress.

May 17, 2024

Oklahoma

DEA 2024 Report Focuses on THC Potency, Organized Crime, Youth Edible Consumption

The federal agency’s National Drug Threat Assessment calls attention to how scheduled substances and trafficking trends are “endangering” the U.S.

May 17, 2024

Cannabis Rescheduling

White House Moves to Reschedule Cannabis in ‘Monumental’ Decision, Biden Says

The Department of Justice will issue a notice of proposed rulemaking to reclassify cannabis in the Federal Register, which will be followed by a 60-day public comment period prior to the department potentially finalizing the rule.

May 16, 2024

Cannabis Rescheduling

Cannabis Rescheduling Reactions Mixed: While Some Applaud Potential, Others Push For More

Executives, lawmakers and nonprofit leaders weigh in on the significance and shortcomings of the DEA's move to reclassify cannabis as a less dangerous substance.

May 1, 2024

Cannabis Rescheduling

21 US Lawmakers Express Frustration With DEA’s Inaction on Cannabis Rescheduling

The 11 senators and 10 House representatives urged for swift action to remove cannabis from a Schedule I listing in a new letter.

April 25, 2024

Legislation and Regulation

Federal Cannabis Legalization and Reform: Where Are We in 2024?

U.S. cannabis reform hasn’t come easy amid a divided Congress, but plenty of opportunities remain on the table for the remainder of the year.

April 20, 2024

Cannabis Industry Research

Cannabis Company Sues DEA Over Application to Grow for Clinical Trials

Rhode Island-based MMJ BioPharma Cultivation Inc. is seeking an order to halt the DEA’s ‘unconstitutional actions’ as it awaits approval to grow cannabis.

April 8, 2024

Florida

The Future of Hemp-Derived Delta-9 THC Headlines CBT’s Most-Read Articles for March

Readers also dove headfirst into Amazon’s delta-8 problems and a potential rescheduling roadblock with the DEA’s five-factor test this month.

March 28, 2024

Cannabis Rescheduling

3 GOP Senators Tell DEA Not to Reschedule Cannabis

Led by former presidential candidate Mitt Romney, the senators argue rescheduling would violate an international treaty in letter to DEA administrator.

March 27, 2024

Cannabis Rescheduling

DEA’s 5-Factor Test Makes Rescheduling Cannabis Impossible

After HHS used its own two-part test to determine the plant’s ‘currently accepted medical use,’ rescheduling opponents urge DEA to keep its five-part test.

March 19, 2024